Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Recordati S.p.A. has updated its ongoing share buyback program, purchasing 63,381 shares between October 28 and November 1, 2024, at an average price of €53.1691. This initiative supports the company’s stock option and incentive plans, enhancing value for shareholders. Recordati, a global pharmaceutical group, remains committed to addressing both common and rare health challenges.
For further insights into IT:REC stock, check out TipRanks’ Stock Analysis page.
